A 69 year old man receiving echothiophate eye drops for glaucoma was given a controlled infusion of succinylcholine during elective surgery for incisional hernia. Neuromuscular blockade was assessed by the measurement of the force of contraction of the adductor pollicis muscle. Only 9.5 mg succinylcholine were required for tracheal intubation and I. I mglmin for maintenance. When the infusion was stopped, recovery of neuromuscular transmission was rapid and uneventful. Plasma cholinesterase activity was 62 per cent below normal, but the enzyme was qualitatively normal. Thus, muscle relaxation can be achieved safely with a succinylcholine infusion in patients with decreased plasma cholinesterase activity if neuromuscular function is closely monitored.
ECHOTHIOPHATE IODIDE (phospholine iodide) eye drops, used in the treatment of glaucoma, are associated with potentiation of the action of succinylcholine. Previous reports discussed the prolonged apnoea which followed the uncontrolled administration of succinylcholine either by bolus injection t or continuous infusion. 2 The present report demonstrates that succinylcholine can be administered safety by continuous infusion to provide controlled neuromuscular blockade sufficient for tracheal intubation and abdominal surgery if the rate of the infusion is adjusted according to the monitored muscle twitch reponse. This can be achieved without the development of dual block or prolonged apnoea when the infusion is stopped.
CASE REPORT
A 69 year old man weighing 68 kg was scheduled for repair of an incisional hernia. He had received general anaesthesia 17 years previously for a cholecystectomy, with thiopentone, gallamine and nitrous oxide-oxygen and halothane. No succinylcholine was given at that time.
He started using pilocarpine eye drops for glaucoma 18 years ago, but they were changed to echothiophate iodide eight years ago. At the time of the present operation, he was receiving echothiophate iodide 0.125 per cent, one drop b.i.d, in both eyes. He was also using epinephrine eye drops. Otherwise, he was in good health and his pre-operative evaluation, including haemogram, routine biochemistry, chest X-ray and electrocardiogram, were within normal limits. He received morphine 10 mg as premedication.
Anaesthesia was induced with thiopentone 350rag (5 mg. kg -~) and maintained with nitrous oxide (70 per cent) with oxygen and enflurane (1-2 per cent), with spontaneous respiration while the peripheral nerve stimulator and force transducer were set up. Neuromuscular transmission was monitored according to the method of All, et al. 3 The ulnar nerve was stimulated supramaximally at the elbow using a subcutaneous needle electrode and a surface electrode. Trains of four with 0.2 millisecond square pulses at a frequency of 2 Hz were repeated every 10 seconds using a Grass $48 stimulator and a SIU5 Isolation Unit. The hand and forearm were immobilized in a splint and the isometric force of contraction of the adductor pollicis muscle was measured with a force-displacement transducer (Grass F.T. 10) and recorded using a pen-and-ink recorder (Grass Polygraph).
About five minutes after induction, when the recording of the train-of-four had stabilized, a succinylcholine infusion (0.5 per cent) was started at 6mg/min (0.09 mg.kg -~.min -t) and the Train-of-four muscle twitch recording demonstrating characteristics of neuromuscular block. twitch response was monitored (Figure la) . A decrease in the twitch height was observed after 60 seconds and by 80 seconds the infusion rate was reduced to 1.5 mg/min. No twitch was detectable 140 seconds after the start of the infusion. After a total succinylcholine dose of only 9.5 mg (0.14mg. kg -t) the patient was apnoeic and the trachea was intubated under excellent conditions.
The patient was ventilated and maintenance of anaesthesia continued with nitrous oxide (70 per cent), oxygen and enflurane (I-2 per cent). Muscle relaxation was provided by adjusting the succinylcholine infusion rate to maintain the height of the first twitch of each train at approximately 10 per cent of the initial value. After intubation, the infusion rate was slowed, then stopped, and although only 12 mg had been given, no muscle twitch was recorded for nine minutes. Subsequent maintenance dosesofsuccinylcholine ranged between 1.0 and 1.2 mg/min (0.015 and 0.018 mg. kg -I. min -~) which provided adequate relaxation for abdominal operation (Figure lb) .
The infusion was stopped after peritoneal closure, 61 minutes after it was started, after a total dose of 71mg (I.04mg. kg -t) had been administered. Ten minutes later the patient began to breathe spontaneously, when the first twitch of the train-of-four was 90 per cent of its initial value and the fourth twitch was 85 per cent of the first ( Figure Ic) . Enflurane was turned off and five minutes later the height of the first twitch had returned to its original value, and the fourth twitch of the train was 95 per cent of the first. The trachea was extubated and recovery was uneventful. During recovery from the neuromuscular blockade, the height of the fourth twitch was 80-90 per cent of that of the first twitch, indicating a predominantly depolarizing block.
Blood was drawn the next day Ibr plasma cholinesterase determination and showed an activity of 22.1 units (N = 49-61); but the dibucaine, fluoride, and chloride numbers were 84, 50 and 16 percent respectively, and thus compatible with a qualitatively normal enzyme.
DISCUSSION
Echothiophate iodide administered as an ophthalmic solution has been found to decrease plasma cholinesterase levels, 4'~ and this prolongs the action of succinylcholine by slowing its metabolism. Our patient's plasma cholinesterase activity was 38 per cent of the mid-range of normal, which was similar to the mean found by Lanks and Sklar 4 (35-52 per cent) in a group of eight patients receiving echothiophate eye drops. The patients who had prolonged apnoea after normal doses of succinylcholine had a plasma cholinesterase activity of 17 per cent ~ and 30 per cent 2 of normal. In our patient, only 9.5 mg were required to abolish the adductor pollicis twitch reponse, and maintenance doses were only l-l.2mg/min. In a group of 20 adult patients anaesthetized by us using the same technique, the mean intubating and maintenance doses were markedly higher, namely 45.9mg and 4.95 mg/min respectively.
The marked effect of succinylcholine in patients receiving echothiophate results, at least in part, from the decreased levels of plasma cholinesterase. In addition, echothiophate is an inhibitor of acetylcholinesterase, which is the reason for its use in ophthalmology. Thus, it potentiales the action of succinylcholine like other anticholinesterases such as neostigmine and edrophonium, and this may explain why only 20 per cent of the normal infusion dose of succinylcholine was required to maintain neuromuscular blockade in a patient whose plasma cholinesterase activity was 38 per cent of normal.
Thus plasma cholinesterase levels are probably not the only predictors of the required dose of succinylcholine, and adequate monitoring of the neuromuscular junction is therefore essential. In our patient plasma cholinesterase levels were not available at operation, but continuous neuromuscular monitoring was sufficient to avoid the problem of prolonged apnoea.t'2 The transducer and recording equipment were used for convenience and to obtain a permanent record, but the same results could probably have been achieved with a conventional 2 Hz nerve stimulator.
The prior administration ofeehothiophate eye drops is one of a large number of congenital and acquired conditions which may affect the plasma cholinesterase in a qualitative or quantitative manner. 6 Many of these are not uncommon, including contraceptive pills, pregnancy, organophosphorous insecticides. This case report suggests that careful monitoring of the neuromuscular junction allows succinylcholine to be used safely in these conditions without the risk of prolonged apnoea.
